175 related articles for article (PubMed ID: 30413077)
1. Folate Receptor-Targeted and GSH-Responsive Carboxymethyl Chitosan Nanoparticles Containing Covalently Entrapped 6-Mercaptopurine for Enhanced Intracellular Drug Delivery in Leukemia.
Wei X; Liao J; Davoudi Z; Zheng H; Chen J; Li D; Xiong X; Yin Y; Yu X; Xiong J; Wang Q
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30413077
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan.
Gong XY; Yin YH; Huang ZJ; Lu B; Xu PH; Zheng H; Xiong FL; Xu HX; Xiong X; Gu XB
Int J Pharm; 2012 Oct; 436(1-2):240-7. PubMed ID: 22750430
[TBL] [Abstract][Full Text] [Related]
3. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia.
Qiu J; Cheng R; Zhang J; Sun H; Deng C; Meng F; Zhong Z
Biomacromolecules; 2017 Oct; 18(10):3207-3214. PubMed ID: 28835099
[TBL] [Abstract][Full Text] [Related]
5. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system.
Dorniani D; Hussein MZ; Kura AU; Fakurazi S; Shaari AH; Ahmad Z
Drug Des Devel Ther; 2013; 7():1015-26. PubMed ID: 24106420
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and in vitro drug release behavior of glutathione-sensitive long-circulation micelles based on polyethylene glycol prodrug.
Shi L; Ding K; Sun X; Zhang L; Zeng T; Yin Y; Zheng H
J Biomater Sci Polym Ed; 2016; 27(6):472-89. PubMed ID: 26764973
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
9. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of folate‑chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells.
Cheng L; Ma H; Shao M; Fan Q; Lv H; Peng J; Hao T; Li D; Zhao C; Zong X
Mol Med Rep; 2017 Aug; 16(2):1101-1108. PubMed ID: 28627615
[TBL] [Abstract][Full Text] [Related]
12. Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine.
Cilurzo F; Cristiano MC; Da Pian M; Cianflone E; Quintieri L; Paolino D; Pasut G
Anticancer Agents Med Chem; 2019; 19(12):1513-1522. PubMed ID: 31241440
[TBL] [Abstract][Full Text] [Related]
13. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment.
Kunjiappan S; Panneerselvam T; Govindaraj S; Parasuraman P; Baskararaj S; Sankaranarayanan M; Arunachalam S; Babkiewicz E; Jeyakumar A; Lakshmanan M
Anticancer Agents Med Chem; 2019; 19(16):1966-1982. PubMed ID: 31267878
[TBL] [Abstract][Full Text] [Related]
14. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
[TBL] [Abstract][Full Text] [Related]
16. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery.
Sahu SK; Mallick SK; Santra S; Maiti TK; Ghosh SK; Pramanik P
J Mater Sci Mater Med; 2010 May; 21(5):1587-97. PubMed ID: 20111985
[TBL] [Abstract][Full Text] [Related]
18. Folate-modified carboxymethyl chitosan-based drug delivery system for breast cancer specific combination therapy via regulating mitochondrial calcium concentration.
Lv Y; Chen X; Shen Y
Carbohydr Polym; 2024 Jan; 323():121434. PubMed ID: 37940300
[TBL] [Abstract][Full Text] [Related]
19. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.
Gao C; Liu T; Dang Y; Yu Z; Wang W; Guo J; Zhang X; He G; Zheng H; Yin Y; Kong X
Carbohydr Polym; 2014 Oct; 111():964-70. PubMed ID: 25037437
[TBL] [Abstract][Full Text] [Related]
20. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
